References
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 ;26(1):1–133.
- Fard-Esfahani A, Emami-Ardekani A, Fallahi B, et al. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nucl Med Commun. 2014 ;35(8):808–817.
- La Perle KM, Kim DC, Hall NC, et al. Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid. 2013;23(8):1029–1036.
- Jentzen W, Schneider E, Freudenberg L, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun. 2006;27(8):669–676.
- Geres AE, Szafryk Mereshian P, Fernández S, et al. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment. Endocrinol Nutr. 2015;62(10):493–498.
- Hyer S, Kong A, Pratt B, et al. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol). 2007;19(1):83–86.
- Lee HN, An JY, Lee KM, et al. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose. Clin Imaging. 2015;39(3):396–400.
- Moreddu E, Baumstarck-Barrau K, Gabriel S, et al. Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire. Br J Oral Maxillofac Surg. 2017;55(6):609–612.
- Almeida JP, Sanabria AE, Lima EN, et al. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck. 2011;33(5):686–690.
- Albano D, Bertagna F, Panarotto MB, et al. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr Blood Cancer. 2017;64(11):e26554.
- Lin WY, Shen YY, Wang SJ. Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med. 1996;21(10):780–782.
- Kita T, Yokoyama K, Higuchi T, et al. Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma. Ann Nucl Med. 2004;18(4):345–349.
- Solans R, Bosch JA, Galofre P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42(5):738–743.
- Wu CB, Xi H, Zhou Q, et al. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis. J Oral Maxillofac Surg. 2015;73(3):475–481. Mar
- Cung TD, Lai W, Svider PF, et al. Sialendoscopy in the management of radioiodine induced sialadenitis: a systematic review. Ann Otol Rhinol Laryngol. 2017;126(11):768–773.